NO20014091L - Transplantasjon av hematopoietiske celler - Google Patents

Transplantasjon av hematopoietiske celler

Info

Publication number
NO20014091L
NO20014091L NO20014091A NO20014091A NO20014091L NO 20014091 L NO20014091 L NO 20014091L NO 20014091 A NO20014091 A NO 20014091A NO 20014091 A NO20014091 A NO 20014091A NO 20014091 L NO20014091 L NO 20014091L
Authority
NO
Norway
Prior art keywords
transplantation
hematopoietic cells
disease
treatment
stem cells
Prior art date
Application number
NO20014091A
Other languages
English (en)
Other versions
NO20014091D0 (no
Inventor
Jack Price
Original Assignee
Reneuron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reneuron Ltd filed Critical Reneuron Ltd
Publication of NO20014091L publication Critical patent/NO20014091L/no
Publication of NO20014091D0 publication Critical patent/NO20014091D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Psychology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Transplantasjon av hematopoietiske stamceller for behandling av en skadet hjerne. Intracerebral transplantasjon av hematopoietiske stamceller kan reparere funksjon og kan være egnet for behandling av Alzheimers sykdom, Parkinsons sykdom og Creuzfeld-Jacobs sykdom.
NO20014091A 1999-02-24 2001-08-23 Transplantasjon av hematopoietiske celler NO20014091D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9904281.4A GB9904281D0 (en) 1999-02-24 1999-02-24 Transplantation
PCT/GB2000/000636 WO2000050568A2 (en) 1999-02-24 2000-02-23 Transplantation of haematopoietic cells

Publications (2)

Publication Number Publication Date
NO20014091L true NO20014091L (no) 2001-08-23
NO20014091D0 NO20014091D0 (no) 2001-08-23

Family

ID=10848438

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014091A NO20014091D0 (no) 1999-02-24 2001-08-23 Transplantasjon av hematopoietiske celler

Country Status (20)

Country Link
EP (1) EP1161521B1 (no)
JP (1) JP4716575B2 (no)
KR (1) KR20020000216A (no)
CN (1) CN1636053A (no)
AT (1) ATE237680T1 (no)
AU (1) AU762763B2 (no)
CA (1) CA2361401A1 (no)
CZ (1) CZ20012651A3 (no)
DE (1) DE60002185T2 (no)
DK (1) DK1161521T3 (no)
ES (1) ES2193938T3 (no)
GB (1) GB9904281D0 (no)
HK (1) HK1041284B (no)
HU (1) HUP0105168A3 (no)
NO (1) NO20014091D0 (no)
PL (1) PL350297A1 (no)
PT (1) PT1161521E (no)
RU (1) RU2216336C2 (no)
SK (1) SK11232001A3 (no)
WO (1) WO2000050568A2 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9518606D0 (en) 1995-09-12 1995-11-15 Inst Of Psychiatry Neural transplantation
PT1183035E (pt) * 1999-05-14 2015-03-04 Ford Henry Health System Transplante de medula óssea para tratamento de acidente vascular cerebral
US8017112B2 (en) 1999-05-14 2011-09-13 Henry Ford Health System Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases
JP4623967B2 (ja) * 2002-01-14 2011-02-02 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ 幹細胞の移動および増殖を促進するための修飾されたピリミジン化合物の使用
JPWO2004045666A1 (ja) * 2002-11-15 2006-03-16 株式会社産学連携機構九州 臓器の再生方法
DE602005002430T2 (de) 2004-09-30 2008-06-19 Reneuron Ltd., Guildford Zelllinie
RU2283119C1 (ru) * 2005-03-29 2006-09-10 Андрей Степанович БРЮХОВЕЦКИЙ Препарат аутологичных гемопоэтических стволовых клеток, способ его получения, криоконсервации и использования для лечения травматической болезни центральной нервной системы
US7569545B2 (en) * 2005-05-20 2009-08-04 Academia Sinica Methods of increasing neurotrophic factor expression
CA2647201C (en) 2006-03-24 2016-03-08 Children's Medical Center Corporation Method to modulate hematopoietic stem cell growth
JP5426389B2 (ja) 2006-10-20 2014-02-26 チルドレンズ メディカル センター コーポレーション 組織の再生を亢進するための方法
US8791128B2 (en) 2008-09-16 2014-07-29 University Of Central Florida Research Foundation, Inc. Compositions for treating or delaying the onset of hair loss
WO2010091052A2 (en) 2009-02-03 2010-08-12 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
US9056085B2 (en) 2009-02-03 2015-06-16 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
GB0902034D0 (en) 2009-02-06 2009-03-11 Reneuron Ltd Method
ES2672693T3 (es) * 2011-04-20 2018-06-15 The Regents Of The University Of California Método para el acondicionamiento y quimioselección combinadas en un único ciclo
JP6106688B2 (ja) 2011-12-02 2017-04-05 フェイト セラピューティクス，インコーポレイテッド 虚血を処置する改善された方法
AU2012321088B8 (en) 2011-12-02 2016-12-15 Fate Therapeutics, Inc. Enhanced stem cell composition
EP2968416A4 (en) 2013-03-15 2016-08-17 Fate Therapeutics Inc BIOLOGICAL ACTIVITY TESTING OF CELLS FOR A THERAPEUTIC POTENTIAL
RU2647429C1 (ru) * 2017-02-06 2018-03-15 Федеральное государственное автономное образовательное учреждение высшего образования "Дальневосточный федеральный университет" (ДВФУ) Биомедицинский клеточный препарат
RU2720002C1 (ru) * 2018-12-28 2020-04-23 Андрей Степанович БРЮХОВЕЦКИЙ Биомедицинский клеточный продукт для лечения нервных болезней и психических расстройств, способ его получения и его применение
CN114934072B (zh) * 2022-05-18 2023-10-20 华中科技大学同济医学院附属协和医院 一种人心脏瓣膜间质细胞系的永生化构建方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399493A (en) * 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5612211A (en) * 1990-06-08 1997-03-18 New York University Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
KR950700403A (ko) * 1992-03-04 1995-01-16 죤 제이. 쉬바르츠 조혈 간세포의 배양 및 그것의 유전공학(culturing of hematopoietic stem cells and their genetic engineering)
IL122752A (en) * 1995-06-27 2001-07-24 Boehringer Ingelheim Kg Stable preparations for creating propellant-free sprays
GB9518606D0 (en) * 1995-09-12 1995-11-15 Inst Of Psychiatry Neural transplantation
WO1998007841A1 (en) * 1996-08-19 1998-02-26 University Of Massachusetts Embryonic or stem-like cell lines produced by cross species nuclear transplantation

Also Published As

Publication number Publication date
EP1161521B1 (en) 2003-04-16
ATE237680T1 (de) 2003-05-15
HUP0105168A2 (hu) 2002-05-29
AU2682100A (en) 2000-09-14
NO20014091D0 (no) 2001-08-23
HK1041284B (zh) 2003-10-03
AU762763B2 (en) 2003-07-03
KR20020000216A (ko) 2002-01-05
WO2000050568A3 (en) 2000-12-07
JP4716575B2 (ja) 2011-07-06
GB9904281D0 (en) 1999-04-21
HK1041284A1 (en) 2002-07-05
DK1161521T3 (da) 2003-06-16
ES2193938T3 (es) 2003-11-16
EP1161521A2 (en) 2001-12-12
PL350297A1 (en) 2002-12-02
CN1636053A (zh) 2005-07-06
DE60002185D1 (de) 2003-05-22
HUP0105168A3 (en) 2003-12-29
DE60002185T2 (de) 2003-12-18
CA2361401A1 (en) 2000-08-31
CZ20012651A3 (cs) 2002-01-16
WO2000050568A2 (en) 2000-08-31
SK11232001A3 (sk) 2002-01-07
JP2002537406A (ja) 2002-11-05
PT1161521E (pt) 2003-08-29
RU2216336C2 (ru) 2003-11-20

Similar Documents

Publication Publication Date Title
NO20014091L (no) Transplantasjon av hematopoietiske celler
NO20004803L (no) Smilagening og anzurogenin for behandling av Alzheimers sykdom
DK1303272T3 (da) Benzothiazolderivater til behandling af Alzheimers sygdom og Parkinsons sygdom
DK1224297T3 (da) Alzheimers sygdom -sekretase, APP-substrater derfor og anvendelser deraf
AU2002343557A1 (en) Substituted aryl 1,4-pyrazine derivatives
CA2336833A1 (en) Remedy with antidepressant effects
MXPA02004881A (es) Genes de rasgos o cualidades de las semillas.
BR9709967A (pt) Prótese de válvula mitral.
DK0484281T4 (da) Cyclosporiner
EG23427A (en) Cultivated agarwood.
GB0400167D0 (en) Dopaminergic neurons and proliferation-competent orecursor cells for treating parkinson's disease
FR2808437B1 (fr) Prothese de reparation herniaire
TW367365B (en) An improved method for obtaining plant somatic embryos about the somatic embryo suspension cultures and pro-embryogenic mass suspension cultures
HK1080408B (zh) 溴莫尼定在治療痴呆和帕金森病中的用途
DE69425820T2 (de) Verwendung von ferrioxamin-b zur behandlung septischen schocks
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
DE59707667D1 (de) Prothetische Gelenkpfanne
EP0939264A3 (de) Schnellverschluss
DE19980245D2 (de) Verwendung eines Preßsaftes, Verdauungssaftes oder Extraktes von fleischfressenden Pflanzen zur Hemmung von Proteinkinasen
SE9704458D0 (sv) Anläggning samt förfarande vid en sådan, del 2
IL142240A0 (en) Organic medium for plant cultivation and biological capsule based on the organic medium
GR1004103B (el) Συγκροτημα ξηραντηριου μετα δεματοποιησης χορτονομων (τριφυλιου και λοιπων χορτων)
IT1307785B1 (it) Impianto e kit per la fabbricazione di accoppiati tessili.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application